Showing 1 - 7 results of 7 for search 'Sara J. Adair', query time: 0.03s Refine Results
  1. 1
    Co-Treatment with Panitumumab and Trastuzumab Augments Response to the MEK Inhibitor Trametinib in a Patient-Derived Xenograft Model of Pancreatic Cancer

    Co-Treatment with Panitumumab and Trastuzumab Augments Response to the MEK Inhibitor Trametinib in a Patient-Derived Xenograft Model of Pancreatic Cancer by James M. Lindberg, Timothy E. Newhook, Sara J. Adair, Dustin M. Walters, Alison J. Kim, Edward B. Stelow, J. Thomas Parsons, Todd W. Bauer

    Published 2014-07-01
    Get full text
    Article
  2. 2
    A thirteen-gene expression signature predicts survival of patients with pancreatic cancer and identifies new genes of interest.

    A thirteen-gene expression signature predicts survival of patients with pancreatic cancer and identifies new genes of interest. by Timothy E Newhook, Edik M Blais, James M Lindberg, Sara J Adair, Wenjun Xin, Jae K Lee, Jason A Papin, J Thomas Parsons, Todd W Bauer

    Published 2014-01-01
    Get full text
    Article
  3. 3
    Cancer-oocyte SAS1B protein is expressed at the cell surface of multiple solid tumors and targeted with antibody-drug conjugates

    Cancer-oocyte SAS1B protein is expressed at the cell surface of multiple solid tumors and targeted with antibody-drug conjugates by Craig L Slingluff, Walter C Olson, Christine A Tran, Arabinda Mandal, Jagathpala Shetty, Mriganka Mandal, Bhupal Ban, Eusebio S Pires, Sara J Adair, Todd W Bauer, John C Herr

    Published 2024-03-01
    Get full text
    Article
  4. 4
    Drp1 Promotes KRas-Driven Metabolic Changes to Drive Pancreatic Tumor Growth

    Drp1 Promotes KRas-Driven Metabolic Changes to Drive Pancreatic Tumor Growth by Sarbajeet Nagdas, Jennifer A. Kashatus, Aldo Nascimento, Syed S. Hussain, Riley E. Trainor, Sarah R. Pollock, Sara J. Adair, Alex D. Michaels, Hiromi Sesaki, Edward B. Stelow, Todd W. Bauer, David F. Kashatus

    Published 2019-08-01
    Get full text
    Article
  5. 5
    Clinical, molecular and genetic validation of a murine orthotopic xenograft model of pancreatic adenocarcinoma using fresh human specimens.

    Clinical, molecular and genetic validation of a murine orthotopic xenograft model of pancreatic adenocarcinoma using fresh human specimens. by Dustin M Walters, Jayme B Stokes, Sara J Adair, Edward B Stelow, Cheryl A Borgman, Bryce T Lowrey, Wenjun Xin, Edik M Blais, Jae K Lee, Jason A Papin, J Thomas Parsons, Todd W Bauer

    Published 2013-01-01
    Get full text
    Article
  6. 6
    Inhibition of the Growth of Patient-Derived Pancreatic Cancer Xenografts with the MEK Inhibitor Trametinib Is Augmented by Combined Treatment with the Epidermal Growth Factor Receptor/HER2 Inhibitor Lapatinib

    Inhibition of the Growth of Patient-Derived Pancreatic Cancer Xenografts with the MEK Inhibitor Trametinib Is Augmented by Combined Treatment with the Epidermal Growth Factor Recep... by Dustin M. Walters, James M. Lindberg, Sara J. Adair, Timothy E. Newhook, Catharine R. Cowan, Jayme B. Stokes, Cheryl A. Borgman, Edward B. Stelow, Bryce T. Lowrey, Maria E. Chopivsky, Tona M. Gilmer, John T. Parsons, Todd W. Bauer

    Published 2013-02-01
    Get full text
    Article
  7. 7
    CRISPR knockout screening identifies combinatorial drug targets in pancreatic cancer and models cellular drug response

    CRISPR knockout screening identifies combinatorial drug targets in pancreatic cancer and models cellular drug response by Karol Szlachta, Cem Kuscu, Turan Tufan, Sara J. Adair, Stephen Shang, Alex D. Michaels, Matthew G. Mullen, Natasha Lopes Fischer, Jiekun Yang, Limin Liu, Prasad Trivedi, Edward B. Stelow, P. Todd Stukenberg, J. Thomas Parsons, Todd W. Bauer, Mazhar Adli

    Published 2018-10-01
    Get full text
    Article

Search Tools: